FY2023 EPS Estimates for Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Lifted by HC Wainwright
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Analysts at HC Wainwright upped their FY2023 earnings estimates for Aclaris Therapeutics in a report released on Monday, January 22nd. HC Wainwright analyst R. Selvaraju now anticipates that the biotechnology company will post earnings of ($1.65) per share for the year, up from their previous forecast of […]